Janssen Romania invested EUR 154,000 in first cancer palliative care program

Janssen Romania, the pharmaceuticals arm of multinational group Johnson & Johnson, has invested EUR 154,000 in the development of the first curriculum for the palliative care of cancer patients, said Christian Rodseth, managing director of Janssen Romania, business-review.eu reads. The investment was carried out as part of the company’s community involvement platform. According to statistics, some 160,000 patients need ...

Developed by Codecraftsman